Cadila Healthcare Ltd on Monday said it has decided to close its Japanese subsidiary set up in 2006 to tap the world’s second-largest pharmaceutical market. “The company has recently completed portfolio and strategy review of its business and has decided to exit from its business in Japan, which is through a 100% subsidiary company,” Cadila Healthcare said in a statement to the stock exchanges on Monday, without specifying a reason. Cadila, also known as Zydus Cadila, set up Zydus Pharma Inc. in 2006 to tap Japan’s emerging market for copycat drugs.
Help employers find you! Check out all the jobs and post your resume.
